We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (270)
- COVID-19 (163)
- Safety monitoring and information (96)
- Legislation (93)
- Compliance and enforcement (61)
- Manufacturing (51)
- Vaping hub (51)
- Labelling and packaging (34)
- Scheduling (national classification system) (27)
- Medicinal cannabis hub (25)
- Import and export (24)
- Sunscreens (16)
- Shortages and supply disruptions (14)
- Weight loss products (14)
- Committees and advisory bodies (9)
- Cosmetics (4)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1245 result(s) found, displaying 126 to 150
-
News articlesFollowing a request from the sponsor to reconsider their decision, the TGA has confirmed the initial decision to not register the medicine on the basis that the safety and efficacy of the medicine were not satisfactorily established.
-
Regulatory decision noticesListed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2025, which commenced on 1 March 2025
-
News articlesFrom 1 March 2025, sponsors of vaping goods will be able to use a new online form of the sponsor notice.
-
Regulatory decision noticesThis instrument is made under Schedule 5A to the Therapeutic Goods Regulations 1990 and Schedule 4 to the Therapeutic Goods (Medical Devices) Regulations 2002.
-
News articlesWe are updating information for nitrosamine impurities and other nitroso-structure impurities in medicines including acceptable intakes (AI)
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
News articlesThe TGA has released a literature review of certain active ingredients used in sunscreens.
-
BlogAustralians who use tanning products containing ‘melanotan’ are at risk of serious health problems.
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
Media releasesWe have issued a combined total of $396,000 in infringement notices to 20 Melbourne retail businesses for the alleged unlawful supply of vaping goods.
-
News articlesYour feedback is essential to shaping a user-friendly website that works better for everyone.
-
Safety updatesAdditional safety information is being added to all montelukast products to strengthen and highlight existing warnings about serious neuropsychiatric events.
-
Regulatory decision noticesThis consent is given under sections 14 and 14A of the Therapeutic Goods Act 1989.
-
Regulatory decision noticesThis instrument is made under subsections 19(5AA), 32CM(1A) and 41HC(1A) of the Therapeutic Goods Act 1989.
-
Therapeutic Goods (Special Access Scheme - Application and Notification Forms) Approval (No. 2) 2024
Regulatory decision noticesThis instrument is made under the Therapeutic Goods Regulations 1990, the Therapeutic Goods (Medical Devices) Regulations 2002 and the Therapeutic Goods Act 1989. -
Media releasesThe defendant faces a maximum penalty of 12 months’ imprisonment and/or a fine of up to $222,000 for each charge.
-
News articlesRecall reforms program update and preview of the PRAC Version 1.0.
-
Media releasesWe have issued infringement notices totalling $37,560 for the alleged unlawful possession of a commercial quantity of vaping goods.
-
Safety updatesTCMs sold in Australia are carefully regulated to ensure safety and quality.
-
Media releasesThe TGA and cooperating agencies have seized a large volume of alleged illicit vapes, tobacco and other substances in coordinated operations across Australia.
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
News articlesFind out about new requirements for labels of injectable electrolyte medicines and updates to guidance for medicine sponsors.
-
Regulatory decision noticesMRA GMP clearances that are expiring on 31 December 2024 will be automatically extended.
-
BlogIf your business sells or advertises paracetamol, then you need to be aware of the new rules around pack sizes that commence on 1 February 2025.
-
BlogWe know that paracetamol is safe and effective for most people when taken at the recommended dose.